Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Novel Approaches in Cancer Study

Awareness about Liver Cancer in Biotechnology Students

  • Open or Close Muhammad Imran Qadir* and Sidra Noureen

    Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Pakistan

    *Corresponding author: Muhammad Imran Qadir, Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan

Submission: April 12, 2018; Published: May 29, 2018

DOI: 10.31031/NACS.2018.01.000517

ISSN:2637-773X
Volume1 Issue4

Abstract

Liver cancer is a major disease caused by sudden mutation occurred in the genes. To cure this disease gemcitabine seems to be affective. Gemcitabine is anticancer agent that has profile containing mild toxicity. It seems to be affective in solid tumors. To check its effectiveness, a questionnaire was developed and the awareness about liver cancer is checked in the post graduate students. All the students were fully aware of this disease.

Keywords: Liver cancer; Mutation; Gemcitabine; Treatment; Effectiveness

Get access to the full text of this article


About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com